Table 2.
Antimicrobial resistance patterns of Klebsiella species isolated from UTI-suspected patients who attended Bahir Dar City health institutions, Bahir Dar, Northwest Ethiopia, 2019.
| Klebsiella isolates | Sensitivity | Antimicrobials tested for | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP, n (%) | GEN, n (%) | AMC, n (%) | CXT, n (%) | CTX, n (%) | CIP, n (%) | MER, n (%) | COT, n (%) | CAZ, n (%) | CHL, n (%) | NIT, n (%) | ||
| K. pneumoniae (n = 25) | S | 6 (24) | 11 (44) | 1 (4) | 15 (60) | 15 (60) | 16 (64) | 22 (88) | 5 (20) | 17 (68) | 18 (72) | 13 (52) |
| I | 0 | 6 (24) | 4 (16) | 3 (12) | 4 (16) | 4 (16) | 1 (4) | 1 (4.) | 3 (12) | 4 (16) | 5 (20) | |
| R | 19 (76) | 8 (32) | 20 (80) | 7 (28) | 6 (24) | 5 (20) | 2 (8) | 19 (76) | 5 (20) | 3 (12) | 7 (28) | |
|
| ||||||||||||
| K. ozaenae (n = 6) | S | 0 | 5 (83.3) | 1 (16.7) | 5 (83.3) | 4 (66.7) | 4 (66.7) | 6 (100) | 1 (16.7) | 5 (83.3) | 5 (83.3) | 5 (83.3) |
| I | 0 | 0 | 0 | 00 | 00 | 1 (16.7) | 0 | 0 | 00 | 0 | 0 | |
| R | 6 (100) | 1 (16.7) | 5 (83.3) | 1 (16.7) | 2 (33.3) | 1 (16.7) | 0 | 5 (83.3) | 1 (16.7) | 1 (16.7) | 1 (16.7) | |
|
| ||||||||||||
| K. oxytoca (n = 4) | S | 0 | 3 (75) | 3 (75) | 2 (50) | 3 (75) | 3 (75) | 4 (100) | 0 | 3 (75) | 3 (75) | 3 (75) |
| I | 0 | 1 (25) | 0 | 1 (25) | 1 (25) | 1 (25) | 0 | 2 (50) | 0 | 0 | 0 | |
| R | 4 (100) | 00 | 1 (25) | 1 (25) | 00 | 00 | 0 | 2 (50) | 1 (25) | 1 (25) | 1 (25) | |
|
| ||||||||||||
| K. rhinoscleromatis (n = 3) | S | 1 (33.3) | 2 (66.7) | 1 (33.3) | 3 (100) | 3 (100) | 2 (66.7) | 2 (66.7) | 1 (33.3) | 2 (66.7) | 2 (66.7) | 2 (66.7) |
| I | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| R | 2 (66.7) | 1 (33.3) | 2 (66.7) | 0 | 0 | 1 (33.3) | 1 (33.) | 2 (66.7) | 33.3 | 1 (33.3) | 1 (33.3) | |
AMP = ampicillin; GEN = gentamicin; AMC = Augmentin; CXT = cefoxitin; CTX = cefotaxime; CIP = ciprofloxacin; MER = meropenem; COT = cotrimoxazole; CAZ = ceftazidime; CHL = chloramphenicol; NIT = nitrofurantoin; S = sensitive; I = intermediate; R = resistant.